eduKate Learning Manual
Science | Living World | Innate Immunity | Protein Cascades
Understand → Learn → Explain → Test → Go Deeper

Complement System

How Proteins in Blood Can Mark, Recruit and Punch Holes Without Waiting for a Cell to Arrive

Wait, What? Some Immune Defence Is Already Floating in Your Blood as Inactive Protein Machinery

When people imagine immunity, they often picture white blood cells rushing toward a microbe.

But blood and tissue fluid also contain proteins that can activate one another in a cascade.

Complement can coat a target for phagocytes, release inflammatory signals and assemble a membrane-damaging pore before a newly recruited immune cell even reaches the site.

The same power creates a danger: if complement activates on healthy host surfaces, the system can damage the organism it is meant to protect.

Quick Answer

The complement system is a network of soluble and membrane-associated proteins that activates through several entry routes. The classical pathway can begin after C1 recognises certain antibody-bound or other target surfaces. The lectin pathway begins when pattern-recognition molecules such as mannose-binding lectin or ficolins engage suitable carbohydrate patterns. The alternative pathway can initiate and, importantly, amplify C3b deposition on permissive surfaces. These pathways generate C3 convertases that cleave C3 into C3a and C3b. C3b covalently tags nearby targets and helps build C5 convertases. C5 cleavage releases the potent inflammatory mediator C5a and starts assembly of the C5b–9 membrane attack complex. Host cells survive because complement is tightly controlled by fluid-phase and surface regulators such as factor H, factor I, CD46, CD55 and CD59.

• C3 convertase: enzyme complex that cleaves C3.
• C3b: major complement opsonin and amplification component.
• Opsonisation: coating a target to make recognition and uptake by phagocytes easier.
• C3a/C5a: soluble complement fragments that influence inflammation and cell recruitment.
• C5 convertase: enzyme complex that cleaves C5.
• MAC: membrane attack complex, built from C5b through C9.
• Complement regulator: protein that limits where, when or how strongly complement acts.

Part 1 — This Page Owns the Protein Cascade, Not the Cells That Use It

The Macrophage Learning Manual owns phagocytic cell biology. The Neutrophil Learning Manual owns rapid granulocyte recruitment and killing. Vaccine and future antibody owners retain adaptive recognition and memory.

This article owns a different scientific job:

How does a distributed protein network turn recognition into amplification, tagging, recruitment and membrane attack?

Part 2 — Complement Is a Cascade Because One Enzyme Activates Many More Molecules

Many complement proteins circulate as inactive precursors or in forms that become active only after cleavage, assembly or surface binding.

Once a convertase forms, one enzyme complex can process many substrate molecules. Newly deposited components can help make more convertases.

This creates amplification: a small initiating event can produce a large local response.

Part 3 — Three Main Entry Routes Converge on C3

The classical, lectin and alternative pathways begin differently but converge on the formation of C3-cleaving enzyme complexes.

Entry route	Typical initiating logic
Classical	C1 complex recognises particular antibody-bound or other activating surfaces.
Lectin	Pattern-recognition molecules bind characteristic carbohydrate arrangements and activate MASP proteases.
Alternative	Low-level C3 activation plus surface-dependent amplification favours C3b accumulation on poorly protected surfaces.

The convergence matters more than memorising three separate lists: all roads create the ability to cleave C3 efficiently.

Part 4 — C3 Is the Central Amplification Hub

C3 is abundant in plasma. C3 convertases cleave it into C3a and C3b.

C3a is released into fluid and can signal through complement receptors. C3b exposes a reactive thioester that allows covalent attachment to nearby molecular surfaces.

C3 cleavage creates one soluble signal and one surface tag.

Explore C3 structure, activation and regulation →

Part 5 — C3b Turns a Surface Into an Immune Message

C3b deposited on a microbial or altered surface can be recognised directly or after processing into fragments such as iC3b by complement receptors on phagocytes.

This is opsonisation: the target becomes easier for macrophages and neutrophils to identify, bind and engulf.

The complement system therefore does not replace phagocytes. It changes the surface so phagocytes can work more efficiently.

Part 6 — The Alternative Pathway Is Also an Amplifier

It is tempting to think of the alternative pathway only as a third independent trigger.

Its most important systems role is amplification. Once C3b is deposited—no matter which route began the process—factor B and factor D can help form alternative-pathway C3 convertases that generate more C3b.

Properdin can stabilise some of these convertases on surfaces.

Explore complement amplification and current pathway-level understanding →

Part 7 — Amplification Needs a Brake or It Becomes Dangerous

A deposited C3b molecule cannot “know” whether it landed on a pathogen or a nearby host cell.

Host protection therefore depends on regulators that rapidly inactivate C3b, accelerate convertase decay or prevent later membrane attack.

The architecture is not simply “activate on microbes.” It is closer to:

activate locally + amplify where protection is weak + shut down aggressively on protected host surfaces.

Part 8 — Factor H and Factor I Protect Host-Like Surfaces

Factor H binds C3b and host-associated molecular patterns such as sialic-acid-rich surfaces more effectively than many microbial surfaces.

It supports factor I cleavage of C3b and accelerates decay of alternative-pathway convertases.

This is a molecular form of contextual recognition: complement does not identify “self” with one universal label, but host surfaces carry regulators and chemical features that make amplification less favourable.

Part 9 — CD46, CD55 and CD59 Form a Surface Defence Layer

Human cells express membrane-bound complement regulators.

• CD46 acts as a cofactor for factor I-mediated inactivation of deposited C3b/C4b.
• CD55 accelerates decay of C3/C5 convertases.
• CD59 interferes with terminal membrane-attack-complex formation.

These regulators make complement an active local contest between amplification and inhibition.

Explore complement regulation in current human-disease biology →

Part 10 — C3a and C5a Turn Protein Cleavage Into Cell Recruitment

Complement is not only a surface-tagging system.

Small cleavage fragments can bind receptors on leukocytes, endothelial cells and other tissues. C5a in particular is a powerful chemoattractant and activator for myeloid cells.

Complement therefore converts a local biochemical event into a change in cell behaviour and vascular inflammation.

Part 11 — C5 Cleavage Begins the Terminal Pathway

When enough C3b accumulates, convertase complexes acquire C5-cleaving capacity.

C5 cleavage generates C5a and C5b. C5b stays associated with subsequent terminal complement components and begins assembly of the membrane attack complex.

Part 12 — C5b–9 Can Build a Pore

C5b sequentially recruits C6, C7, C8 and multiple C9 molecules.

The resulting C5b–9 structure can insert into susceptible membranes and disrupt ion balance or cause lysis.

Gram-negative bacteria are generally more directly vulnerable to MAC-mediated killing than Gram-positive bacteria, whose thick cell wall creates a different barrier.

“Complement punches holes in microbes” is therefore true only for some targets and conditions.

Part 13 — The MAC Is Not Always an Instant Death Sentence

Sublytic quantities of terminal complement can alter signalling, membrane repair and inflammatory responses without immediately lysing a nucleated host cell.

Cells can shed, internalise or repair damaged membrane regions. The terminal pathway is a graded biological interaction, not simply a binary puncture switch.

Part 14 — Antibodies and Complement Are Partners, Not Synonyms

Some antibody classes and arrangements can trigger the classical pathway after binding antigen.

But complement can also be activated without antibody through lectin and alternative mechanisms.

Adaptive recognition can therefore recruit an ancient innate effector cascade, while innate recognition can activate the same cascade independently.

Part 15 — Complement Also Clears Dead Cells and Immune Complexes

Complement participates in physiological housekeeping, including tagging apoptotic material and immune complexes for safe removal.

This makes complement more than an anti-microbial weapon. It is also part of debris management and immune-system maintenance.

Part 16 — The Liver Supplies Much of the Circulating Complement Pool

Many plasma complement proteins are synthesised largely by hepatocytes, although immune and tissue cells can produce complement components locally as well.

This creates a direct route to the Liver Lobule Learning Manual: an organ of metabolism also supplies major soluble immune machinery to blood.

Part 17 — Complement Connects Innate and Adaptive Immunity

Complement fragments influence B-cell activation, antigen handling, follicular responses and T-cell biology.

It is therefore misleading to place complement entirely on one side of a neat “innate versus adaptive” divide.

Its oldest functions are innate, but its effects are woven into adaptive responses.

Part 18 — Different Species Share the Cascade but Not Every Detail

Complement systems are widespread across vertebrates, but protein sequences, activity levels, assay ranges and sensitivity to pathogens vary by species.

Veterinary immunology must interpret complement within the animal being studied rather than applying human reference values or disease associations automatically.

Part 19 — One Health: Complement Is Shared Biology, Pathogens Exploit It Differently

Many pathogens of humans and animals have evolved proteins that bind factor H, inhibit convertases, cleave complement components or prevent terminal attack.

Comparing these evasion strategies across species reveals a recurring evolutionary contest between host defence and pathogen survival.

One Health owns the cross-species transmission and population-health interface. Complement owns the molecular defence machinery being exploited.

Part 20 — Medicine Begins When Complement Activity Needs Clinical Meaning

Clinical Medicine studies inherited complement deficiencies, autoimmune disease, infection susceptibility, haemolytic disorders, kidney disease and conditions treated with complement-targeting drugs.

This Science manual does not interpret C3, C4, CH50, AH50 or other laboratory results for an individual and does not recommend complement-targeting treatment.

Follow One C3 Molecule Through an Amplifying Response

1. An initiating pathway forms a C3 convertase on or near a target surface.
2. The convertase binds C3.
3. C3 is cleaved into C3a and C3b.
4. C3a diffuses away and signals through receptors.
5. C3b exposes a reactive thioester.
6. C3b becomes covalently attached to nearby target molecules.
7. Complement receptors can recognise C3b/iC3b on the surface.
8. Additional C3b helps build more convertase activity and later C5 convertase.
9. C5 is cleaved.
10. C5a recruits and activates inflammatory cells.
11. C5b begins terminal C5b–9 assembly.
12. Host regulators simultaneously try to limit amplification and pore formation.

Think Like a Scientist: How Do We Know Complement Is a Cascade?

• Purify complement proteins and reconstruct activation step by step.
• Remove one component genetically and test which downstream fragments disappear.
• Measure C3/C5 cleavage products over time.
• Use structural methods to resolve convertases and membrane attack complexes.
• Fluorescently image C3b deposition on target surfaces.
• Block regulators such as factor H or CD59 and measure host-cell damage.
• Use haemolytic assays to compare classical and alternative pathway function.

Observation vs Inference

• Observation: complement activation can rapidly amplify C3b deposition and generate inflammatory and terminal-pathway products.
• Inference: complement is a free-floating toxin that attacks only pathogens.
• Problem: activated fragments can deposit near host tissue too.
• Better model: complement is a locally amplified effector network whose safety depends on strong spatial and temporal regulation.

Common Misconceptions and Better Models

Misconception	Better model
Complement is one protein.	It is a network of dozens of interacting soluble and membrane proteins.
Complement works only after antibodies appear.	Lectin and alternative routes can activate independently of antibodies.
The alternative pathway is only a separate trigger.	It is also a major amplification loop for C3b deposition.
C3b kills microbes directly.	Its central role is opsonisation and amplification; terminal components build the MAC.
The MAC kills every pathogen.	Susceptibility differs greatly by membrane/cell-wall structure and regulatory context.
Complement distinguishes self perfectly.	Host protection depends heavily on regulators that suppress accidental amplification.

Can You Explain WHY?

• Why does complement use amplification instead of one-to-one binding?
• Why is C3 a useful convergence point for several recognition pathways?
• Why does C3b make phagocytosis more efficient?
• Why are host-cell regulators essential even if activation begins on a microbe?
• Why can C5a recruit cells even though complement itself is made of proteins?
• Why is the terminal pathway more effective against some microbes than others?

Primary Science / PSLE Bridge

• Blood carries dissolved proteins as well as cells.
• One chemical reaction can trigger another.
• Tags can make targets easier to recognise.
• Control systems need both accelerators and brakes.
• Body defences can work before a large number of immune cells arrive.

Go Beyond Primary Science

Simple idea	Higher-resolution route
Blood proteins attack germs	Pathway initiation → convertase formation → complement cleavage
Germs are tagged	C3b deposition → iC3b/complement receptor recognition
Inflammation recruits cells	C3a/C5a receptor signalling
Complement makes holes	C5b → C6 → C7 → C8 → C9 polymerisation
Body cells are protected	Factor H/I + CD46/CD55/CD59 regulation

Evidence Boundary

Textbook diagrams often depict three clean pathways feeding one linear terminal cascade. Real complement biology includes cross-talk, local intracellular and tissue complement, non-canonical proteases, surface-specific regulation and context-dependent signalling. The three-pathway model remains highly useful, but the system behaves more like a regulated network than three isolated pipes.

Edge Science — A Defence System That Works by Controlled Instability

Complement proteins circulate together for years without normally triggering catastrophic self-damage.

The network is designed so components are stable enough to coexist, but once the right surface and proteolytic sequence appear, local amplification becomes rapid.

The system is powerful because it is almost unstable—and safe only because several brakes act at every stage.

Manual Summary

• KNOW: complement is an amplifying protein-cascade network centred on C3.
• CONNECT: recognition pathways, C3b opsonisation, inflammatory fragments, phagocytes and MAC form one defence route.
• EXPLAIN: convertases transform local recognition into amplified tagging and downstream effector functions.
• APPLY: trace one C3 molecule from cleavage to opsonisation and C5 activation.
• CHECK: distinguish complement proteins from the immune cells that respond to them.

eduKateAI Direction Graph

• Canonical object: complement cascade
• Owner: Living World / innate immunity / soluble effector proteins
• Object type: regulated proteolytic amplification network
• Scale: protein cleavage → convertase → opsonin/anaphylatoxin → target surface → immune-cell recruitment → organism defence
• Core mechanism: pathway initiation → C3 convertase → C3b amplification/opsonisation → C5 activation → inflammatory signalling/MAC → regulatory shutdown
• Routes to: macrophage, neutrophil, liver lobule, vaccine/antibody, spleen, thymus, infection biology, One Health, Medicine, Veterinary Science
• Boundary case: complement cascade ≠ phagocyte cell biology or adaptive immune memory
• Personalised diagnosis allowed: no

Where to Go Next

• Macrophage | How an Immune Cell Can Eat a Microbe, Clear a Dead Cell and Help Rebuild Tissue
• Neutrophil | How an Immune Cell Can Eat, Oxidise and Throw DNA Nets at Microbes
• Liver Lobule | How Blood From Your Gut Meets Oxygen-Rich Blood Inside a Chemical Processing Organ
• Spleen | How Blood Cells Are Forced Through a Mechanical Quality-Control Test
• Thymus | How the Immune System Teaches T Cells What They Must Recognise—and What They Must Not Attack

Research Sources and Further Reading

• Complement in Human Disease: Regulation and Therapeutic Biology
• Complement-Targeted Therapeutics: Pathway Architecture and Amplification
• Complement Component C3: Structural Perspective and Regulation

---

Teaching Guide for Parents, Tutors and Teachers

Begin with one question: “Can the immune system attack before a white blood cell reaches the microbe?”

Teach C3 as the centre before teaching all pathway names. First establish three outcomes: tag the surface, call cells, damage susceptible membranes. Then show that several recognition routes converge on the same amplification machinery.

For advanced learners, make regulation as important as activation. A student who knows C3b, C5a and MAC but cannot explain factor H/CD55/CD59 has learned the weapon without learning why the host survives using it.